Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Adult T-Cell Leukemia-Lymphoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Adult T-Cell Leukemia-Lymphoma Understanding The ... Read More
-
Chronic Myelocytic Leukemia (CML) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Chronic Myelocytic Leukemia ... Read More
-
Renal cell carcinoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Renal cell carcinoma Understanding The ... Read More
-
Recurrent or Metastatic Head and Neck cancer - Epidemiology Forecast to 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Microsatellite Stable Colorectal Cancer - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Microsatellite Stable Colorectal ... Read More
-
Relapsed Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Relapsed ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Chronic Lymphocytic Leukemia ... Read More
-
BRAF-Mutant Metastatic Melanoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 BRAF-Mutant Metastatic Melanoma Understanding The ... Read More
-
HER2-Negative Breast Cancer - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER2-Negative Breast Cancer Understanding The ... Read More
-
Low-Grade Upper Tract Urothelial Cancer (LG UTUC) - Epidemiology Forecast to 2032
... the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan ... Read More
-
Human Papillomavirus-positive Oropharyngeal Cancer - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Human Papillomavirus-positive Oropharyngeal ... Read More
-
ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast -2032
... Mutated Metastatic Breast Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The ESR1 Mutated Metastatic Breast Cancer market report provides current treatment practices, emerging drugs, ESR1 ... Read More
-
Metastatic HER2 positive breast cancer - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
Advanced Urothelial Carcinoma - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Advanced Urothelial Carcinoma Understanding The ... Read More
-
Recurrent or Metastatic Nasopharyngeal Carcinoma - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Recurrent ... Read More
-
Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
... Diagnostics market in the 7 major pharmaceutical markets. The report also gives a brief competitive analysis of both the current and emerging products, to help understand the competition in the market. Liquid Biopsy for Cancer ... Read More
-
Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic ... Read More
-
B-Cell Non-Hodgkin Lymphoma - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 B-Cell Non-Hodgkin Lymphoma Understanding The ... Read More
-
Urothelial Carcinoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Urothelial Carcinoma Understanding The DelveInsight Urothelial Carcinoma ... Read More
-
Nevoid Basal Cell Carcinoma Syndrome (NBCCS) - Epidemiology Forecast - 2032
... i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: ... Read More
-
Neuroendocrine Carcinoma - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Neuroendocrine Carcinoma Understanding The DelveInsight Neuroendocrine Carcinoma ... Read More
-
Lung Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis
... the main aim of lung cancer screening is to detect lung cancer at its earliest and most treatable stage. Collectively, screening tests involve lab tests that monitor blood and other fluids, genetic tests that study ... Read More
-
Surgery and Radiation Therapy in Brain Cancer- Market Insight, Competive Landscape and Market Forecast- 2026
... understanding of Surgery and Radiation Therapy in Brain Cancer and the historical and forecasted Surgery and Radiation Therapy in Brain Cancer market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Surgery ... Read More
-
Checkpoint Inhibitor Refractory Cancer -Epidemiology Forecast 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Checkpoint Inhibitor Refractory ... Read More
Research Assistance
